Who qualifies for lenacapavir?: Eligibility for PrEP and Multi-Drug Resistant HIV Treatment
•
4 min read
Lenacapavir is a first-in-class, long-acting HIV capsid inhibitor administered as a twice-yearly injection, a significant advancement in HIV care. Understanding who qualifies for lenacapavir is crucial, as eligibility depends on its intended use for either prevention (PrEP) or treating multi-drug resistant HIV.
